Diaoyi Tan

Statistics

Publications

Citations

133

H-Index

Active since

2023

Affiliations

Huazhong University of Science and Technology(Current)

Union Hospital

Wuhan Union Hospital

Union Hospital

Diaoyi Tan is an author at Huazhong University of Science and Technology specializing in molecular oncology, tumor suppressor pathways, and metabolic reprogramming.

ORCID

Publications per year

2023–2024

Publications

N6‐methyladenosine‐modified <i>DBT</i> alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis‐regulated Hippo pathway

Daojia Miao, Qi Wang, Jian Shi et al. · Cancer Communications · 2023 · 50 citations · Full text

Medicine, Cancer Biology, Oncology +17

NAT10‐mediated ac <sup>4</sup> C‐modified ANKZF1 promotes tumor progression and lymphangiogenesis in clear‐cell renal cell carcinoma by attenuating YWHAE‐driven cytoplasmic retention of YAP1

Daojia Miao, Jian Shi, Qingyang Lv et al. · Cancer Communications · 2024 · 34 citations · Full text

Medicine, Cancer Biology, Genetics +16

miR-1182-mediated ALDH3A2 inhibition affects lipid metabolism and progression in ccRCC by activating the PI3K-AKT pathway

Qingyang Lv, Jian Shi, Daojia Miao et al. · Translational Oncology · 2023 · 15 citations · Full text

Medicine, Cancer Biology, Oncology +17

HIF2α Promotes Cancer Metastasis through TCF7L2-Dependent Fatty Acid Synthesis in ccRCC

Jian Shi, Qingyang Lv, Daojia Miao et al. · Research · 2024 · 13 citations · Full text

Medicine, Cancer Biology, Oncology +17

N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway

Diaoyi Tan, Daojia Miao, Chuanyi Zhao et al. · Cell Death and Disease · 2024 · 11 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–5 of 6